TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 73 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $290,000 | -7.9% | 42,362 | -4.0% | 0.00% | 0.0% |
| Q2 2017 | $315,000 | -43.4% | 44,122 | -27.2% | 0.00% | -50.0% |
| Q1 2017 | $557,000 | +468.4% | 60,622 | +148.2% | 0.00% | – |
| Q4 2016 | $98,000 | +6.5% | 24,422 | +1.3% | 0.00% | – |
| Q3 2016 | $92,000 | -11.5% | 24,109 | 0.0% | 0.00% | – |
| Q2 2016 | $104,000 | -7.1% | 24,109 | 0.0% | 0.00% | – |
| Q1 2016 | $112,000 | -53.7% | 24,109 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $242,000 | +38.3% | 24,109 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $175,000 | -91.1% | 23,408 | -43.6% | 0.00% | -87.5% |
| Q2 2015 | $1,968,000 | +162.1% | 41,478 | +102.5% | 0.01% | +166.7% |
| Q1 2015 | $751,000 | -3.8% | 20,484 | +4.2% | 0.00% | 0.0% |
| Q4 2014 | $781,000 | +132.4% | 19,667 | +16.8% | 0.00% | +200.0% |
| Q3 2014 | $336,000 | +48.7% | 16,842 | +0.5% | 0.00% | 0.0% |
| Q2 2014 | $226,000 | +93.2% | 16,761 | +56.5% | 0.00% | 0.0% |
| Q1 2014 | $117,000 | -19.3% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $145,000 | +39.4% | 10,709 | +17.0% | 0.00% | – |
| Q3 2013 | $104,000 | +316.0% | 9,156 | +153.2% | 0.00% | – |
| Q2 2013 | $25,000 | – | 3,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |